Vevorisertib trihydrochloride, 5mg

Vevorisertib trihydrochloride is a selective and effective pan-AKT and AKT1-E17K mutation inhibitor for the study of liver cancer and advanced solid tumors.

• Size: 5mg
• Purity: ≥98%
• Molecular Formula: C 3 5 H 4 1 Cl 3 N 8 O
• Molecular Weight: 696.11
• Physical State: White to light yellow Solid
• Storage: Powder:2-8℃, 2 years;Insolvent(mother liquid):-20℃, 6 months;-80℃, 1 year
• Brand: Saint Michael
• Catalogue No.: IV1680-5mg

For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.